3 active trials 2 recruiting 1 Phase 3 5 disease areas
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT04220190 | RAPA-501 Therapy for ALS | Amyotrophic Lateral Sclerosis | Recruiting | 2025-06-18 |
| Phase 2 | ||||
| NCT06708455 | Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma | Malignant Melanoma With Metastasis | Not Yet Recruiting | 2026-03-19 |
| Phase 1/2 | ||||
| NCT05144698 | RAPA-201 Therapy of Solid Tumors | Solid Tumor | Recruiting | 2025-05-14 |
Melanoma (2) · ALS (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Lung Cancer (1) · Head & Neck Cancer (1)